Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Keywords:
Grouped Articles
E-Mails Highlight Extent of Obama's Deal With Industry on Health Care
New York Times 06/08/2012
Emails Reveal How the White House Bought Big Pharma
Wall Street Journal 06/12/2012
Wall Street Journal 06/11/2012
Americans worry, cheer as Congress moves to upend the Affordable Care Act
Washington Post 03/22/2017
The influence on legislation and federal regulation that the pharmaceutical companies and industry associations are seeking, with $168 million spent on lobbying in 2006. As a result pricing of pharmaceutical products and healthcare services is the major unsolved problem in the U.S.
Grouped Articles
Wall Street Journal 06/25/2008
Health-Care Firms Have Supported Lawmakers Debating Reform
Washington Post 07/21/2009
Dana Milbank - Washington Sketch: GOP's Steele Couldn't Have Said It Better Himself
Washington Post 07/21/2009
Obama's Health Expert Gets Political
Wall Street Journal 07/24/2009
New York Times 08/02/2009
As Congress Goes on Break, Health Lobbying Heats Up
Wall Street Journal 08/05/2009
Finance industry lobbying, with $300 million alone spent to repeal the Glass Steagall Act which kept banks from getting involved in the securties business, is having the effect of making changes without the due diligence and care necessary for changing legislation that had deep reason embedded in experience during the Great Depression. Citigroup's failure is a result of its involvement in the securities business, and it was a principal backer for the repeal. Similar situation is playing out in the U.S. health-care area which has overtaken the finance industry in money spent for lobbying. Lobbying of this magnitude is having distortional effects on national priorities on necessary regulation, and on creating sustainable economical systems for health care in health care laws.
Grouped Articles
Banks' Lobbyists Help in Drafting Financial Bills
New York Times 05/23/2013
New York Times 04/10/2009
Finance Lobby Cut Spending as Feds Targeted Wall Street
Wall Street Journal 07/02/2009
New York Times 07/20/2009
New York Times 07/20/2009
Doctors' Payments Snag Health Bill
Wall Street Journal 07/20/2009
Failure of the Byron Dorgan legislation by 9 votes in the Senate even thogh a coalition of Democrats and Republicans support it, with the Obama Administration opposing it. President Obama turns his back on action that he supported to help Americans hurt hig prescription costs, after pharmaceutial industry lobbyists are able to influence the Obama administration. Just as in the banking industry the Obama adminsitration is letting lobbyists influence its policies.
Grouped Articles
President Obama writes a new health reform prescription
Washington Post 12/16/2009
Wall Street’s resurgent prosperity frustrates its claims, and Obama’s - The Washington Post
Washington Post 11/07/2011
What caused the financial crisis? The Big Lie goes viral - The Washington Post
Washington Post 11/07/2011
A grim diagnosis for our ailing U.S. health care system - The Washington Post
Washington Post 11/28/2011
AARP Study Says Price of Popular Drugs Rose 26%
New York Times 03/06/2012
White House visitor logs show lobbying going strong - The Washington Post
Washington Post 05/21/2012
How the failure to articulate and direct its plans for healthcare reforms is leaving it to the vagaries of politics and the views of individual Senators, Congressmen and lobbyists. As a result pricing of pharmaceutical products and healthcare services remains the major unsolved problem in the U.S.
Grouped Articles
President Obama writes a new health reform prescription
Washington Post 12/16/2009
Eugene Robinson - Which lawmakers can, and can't, play the health-care game
Washington Post 12/18/2009
Health-care bill wouldn't bring real reform
Washington Post 12/17/2009
Liberal Revolt on Health Care Stings White House
New York Times 12/18/2009
New York Times 12/18/2009
A Race to Win One More Vote for Health Bill
New York Times 12/18/2009
The political process and the influence of lobbyists on Congress and the White House constrains the development of laws that control healthcare costs. Higher health care costs means less money for infrastructure development, education, research and development funding, and other priorities which build a future for Americans.
Linked Articles
E-Mails Highlight Extent of Obama's Deal With Industry on Health Care
New York Times 06/08/2012
Obama's Health Expert Gets Political
Wall Street Journal 07/24/2009
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1